首站-论文投稿智能助手
典型文献
Metformin booster adipocyte-targeted gene therapy for the treatment of obesity and related metabolic syndromes
文献摘要:
Obesity has become an important public problem that endangers human conditions and urgently needs to be solved.However,most weight-loss drugs on the market have little effect and are accompanied by adverse effects such as strokes and heart attacks.Here,we construct an adipocyte-targeting polypeptide-based gene carrier consisting of an adipocyte-targeting peptide and p-toluylsulfonyl arginine-modified polylysine(ATS-PLL-RT),which can specifically bind to the prohibitin of mature adipocytes.We further construct a short hairpin RNA(shRNA)to simultaneously silence fatty acid binding proteins 4 and 5(shFABP4/5).FABPs are molecular chaperones for fatty acid metabolism and storage in cells.Moreover,we introduce metformin for combined therapy.First,the metformin combination can effectively improve the efficiency of gene transfection.In addition,metformin itself has an alleviating effect on diet-induced obesity and relevant metabolic diseases.The combination treatment of obese mice with ATS-PLL-RT/shFABP4/5 and metformin achieves body weight reduction and metabolic recovery.This study provides a potentially effective strategy for the clinical treatment of obesity as well as mitigating obesity-induced metabolic syndromes.
文献关键词:
作者姓名:
Jie Chen;Jee Young Chung;Huapan Fang;Lin Lin;Yong-Hee Kim;Huayu Tian;Xuesi Chen
作者机构:
Key Laboratory of Polymer Ecomaterials,Changchun Institute of Applied Chemistry,Chinese Academy of Sciences,Changchun 130022,China;Department of Bioengineering,Institute for Bioengineering and Biopharmaceutical Research,BK 21 Plus Future Biopharmaceutical Human Resources Training and Research Team,Hanyang University,133-791 Seoul,Republic of Korea
引用格式:
[1]Jie Chen;Jee Young Chung;Huapan Fang;Lin Lin;Yong-Hee Kim;Huayu Tian;Xuesi Chen-.Metformin booster adipocyte-targeted gene therapy for the treatment of obesity and related metabolic syndromes)[J].中国科学:化学(英文版),2022(04):796-809
A类:
toluylsulfonyl,shFABP4
B类:
Metformin,booster,targeted,gene,therapy,treatment,obesity,related,metabolic,syndromes,Obesity,has,become,important,public,problem,that,endangers,human,conditions,urgently,needs,solved,However,most,weight,loss,drugs,market,have,little,are,accompanied,by,adverse,effects,such,strokes,heart,attacks,Here,construct,targeting,polypeptide,carrier,consisting,arginine,modified,polylysine,ATS,PLL,which,can,specifically,prohibitin,mature,adipocytes,We,further,short,hairpin,shRNA,simultaneously,silence,fatty,acid,binding,proteins,FABPs,molecular,chaperones,metabolism,storage,cells,Moreover,introduce,metformin,combined,First,combination,effectively,improve,efficiency,transfection,In,addition,itself,alleviating,diet,induced,relevant,diseases,obese,mice,achieves,body,reduction,recovery,This,study,provides,potentially,strategy,clinical,well,mitigating
AB值:
0.616207
相似文献
Nanoparticles targeting at methylases with high correlation to N6-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma
Ruixuan Chen;Ping Ouyang;Licong Su;Xi Xu;Penghu Lian;Yanqin Li;Qi Gao;Yifan Zhang;Sheng Nie;Fan Luo;Ruqi Xu;Xiaodong Zhang;Xiaoxi Li;Yue Cao;Peiyan Gao;Juanjuan Kang;Jun Wu;Lu Li-National Clinical Research Center for Kidney Disease,State Key Laboratory of Organ Failure Research,Guangdong Provincial Clinical Research Center for Kidney Disease,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Health Management,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Hematology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Urology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College(CAMS&PUMC),Beijing 100730,China;Department of Urology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Affiliated Foshan Maternity&Child Healthcare Hospital,Southern Medical University,Foshan 528000,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Radiation Oncology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China
Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors
Elena I.Shramova;Stepan P.Chumakov;Victoria O.Shipunova;Anastasiya V.Ryabova;Georgij B.Telegin;Andrei V.Kabashin;Sergey M.Deyev;Galina M.Proshkina-Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry,Russian Academy of Sciences,16/10 Miklukho-Maklaya Street,Moscow 117997,Russia;MEPhI(Moscow Engineering Physics Institute),Institute of Engineering Physics for Biomedicine(PhysBio),31 Kashirskoe shosse,Moscow 115409,Russia;Prokhorov General Physics Institute,Russian Academy of Sciences,Vavilova,38,Moscow 119991,Russia;Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry,Russian Academy of Sciences,Prospect Nauki 6,Pushchino 142290,Russia;Aix Marseille University,CNRS,LP3,163 Ave.De Luminy,Case 917,13288 Marseille,France
Diet high in branched-chain amino acid promotes PDAC development by USP1-mediated BCAT2 stabilization
Jin-Tao Li;Kai-Yue Li;Ying Su;Yuan Shen;Ming-Zhu Lei;Fan Zhang;Miao Yin;Zheng-Jun Chen;Wen-Yu Wen;Wei-Guo Hu;Dan Su;Jia Qu;Qun-Ying Lei-Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences;Cancer Institutes;Key Laboratory of Breast Cancer in Shanghai;Shanghai Key Laboratory of Medical Epigenetics;International Co-Laboratory of Medical Epigenetics and Metabolism,Ministry of Science and Technology,Shanghai Medical College,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Biology,Shanghai Institute of Biochemistry and Cell Biology,Center for Excellence in Molecular Cell Science,Chinese Academy of Sciences,Shanghai 200031,China;Cancer Research Institute,Zhejiang Cancer Hospital and Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology of Zhejiang Province,Hangzhou 310022,China;Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China;State Key Laboratory of Medical Neurobiology,Fudan University,Shanghai 200032,China
Hybrid nanogenerator based closed-loop self-powered low-level vagus nerve stimulation system for atrial fibrillation treatment
Yu Sun;Shengyu Chao;Han Ouyang;Weiyi Zhang;Weikang Luo;Qingbin Nie;Jianing Wang;Changyi Luo;Gongang Ni;Lingyu Zhang;Jun Yang;Hongqing Feng;Gengsheng Mao;Zhou Li-Department of Neurosurgery,General Hospital of Armed Police Forces,Anhui Medical University,Hefei 230032,China;Department of Neurosurgery,The Third Medical Centre,Chinese People's Liberation Army General Hospital,Beijing 100039,China;Beijing Key Laboratory of Micro-nano Energy and Sensor,Beijing Institute of Nanoenergy and Nanosystems,Chinese Academy of Sciences,Beijing 101400,China;School of Nanoscience and Technology,University of Chinese Academy of Sciences,Beijing 100049,China;Institute of Integrative Medicine.Department of Integrated Traditional Chinese and Western Medicine,Xiangya Hospital,Central South University,Changsha 410008,China;Department of Neurosurgery,Peking University Third Hospital,Beijing 100191,China;School of Chemistry and Chemical Engineering,Center on Nanoenergy Research,Guangxi University,Nanning 530004,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid,prolonged,and broad protection against SARS-CoV-2
Junyu Chen;Pui Wang;Lunzhi Yuan;Liang Zhang;Limin Zhang;Hui Zhao;Congjie Chen;Xijing Wang;Jinle Han;Yaode Chen;Jizong Jia;Zhen Lu;Junping Hong;Zicen Lu;Qian Wang;Rirong Chen;Ruoyao Qi;Jian Ma;Min Zhou;Huan Yu;Chunlan Zhuang;Xiaohui Liu;Qiangyuan Han;Guosong Wang;Yingying Su;Quan Yuan;Tong Cheng;Ting Wu;Xiangzhong Ye;Tianying Zhang;Changgui Li;Jun Zhang;Huachen Zhu;Yixin Chen;Honglin Chen;Ningshao Xia-State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics,National Institute of Diagnostics and Vaccine Development in Infectious Diseases,School of Life Sciences,School of Public Health,Xiamen University,Xiamen 361102,China;State Key Laboratory of Emerging Infectious Diseases,School of Public Health,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong 999077,China;National Institute for Food and Drug Control,Beijing 102629,China;Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd.,Beijing 102206,China;Guangdong-Hong Kong Joint Laboratory of Emerging Infectious Diseases/Joint Laboratory for International Collaboration in Virology and Emerging Infectious Diseases,Joint Institute of Virology(STU/HKU),Shantou University,Shantou 515063,China;EKIH Pathogen Research Institute,Shenzhen 518067,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。